The role of machine learning in cancer drug development
Drug Discovery World
SEPTEMBER 5, 2022
These non-coding contributors can also lower protein expression levels, and are generally missed,” says Dr Olga Troyanskaya, Professor at Princeton University, who specialises in developing machine learning models to interpret disease complexity. Each cell population is classified by detecting uniquely coloured chromogens.
Let's personalize your content